Sacramento – – September 23, 2026 -- Ten California home insurers have requested $571 million in combined rate increases under Insurance Commissioner Ricardo Lara's climate-model rules while committing to sell only 12,000 new home insurance policies, according to an analysis of Department of Insurance filings by Consumer Watchdog.
Philadelphia – September 22, 2026 -- IntegriChain will send five senior advisors to three Informa Connect industry conferences this fall, addressing government pricing, 340B compliance, and gross-to-net forecasting for biopharma manufacturers navigating tightening reimbursement rules.
At the Medicaid Drug Rebate Program (MDRP) Summit 2026, running October 5-7 at the Fairmont Chicago Millennium Park, Jeff Baab, Partner of Advisory Services at IntegriChain, will present "Updates on Landscape of Government Pricing and Contracting" on October 7 at 9:40 AM. The same day at 10:50 AM, Clay Willis, also Partner of Advisory Services, will deliver "340B Movement to Have All 340B Claims in One System of Record," covering the rebate model pilot program #2 and updated patient-definition and contract-pharmacy policies.
Seattle and Austin, Texas – September 19, 2026 -- Zillow and Realtor.com have simultaneously launched Preview, a pre-market listing feature giving buyers on both platforms identical early access to homes before they hit the MLS, without requiring any brokerage relationship or special login.
The rollout, first announced as a collaboration in May, marks what the companies call the largest pre-market syndication effort in U.S. residential real estate. Listings are labeled as Preview on both sites and appear to buyers at the same time regardless of platform.
Zillow said over 400 brokerage partners are participating, including Keller Williams, RE/MAX, Leading Real Estate Companies of the World, HomeServices of America, Berkshire Hathaway HomeServices, United Real Estate, Engel & Völkers and Side, with listing volume continuing to grow.
New York – September 19, 2026 -- Medisights, an AI-native platform for life sciences, has completed a study showing purpose-built AI agents can compress months of qualitative physician research into days while tracking the fast-shifting multiple myeloma treatment landscape.
Medisights' clinical-grade AI conducted adaptive, humanized conversations with specialists, with interviews routinely running 45 to 60 minutes -- longer engagement than traditional researchers typically secure with physicians. The extended dialogue captured prescribing rationale and geographic variation in CAR-T referral pathways for multiple myeloma, a disease marked by rapidly evolving treatment practices.